SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

Clinical trial NCT05435742 · TERMINATED

Trial details

NCT number: NCT05435742
Sponsor: Sonnet BioTherapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Start date: 2022-10-27
Primary completion: 2024-03-17
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.